Get a quote

We're excited to learn more about your project and provide you with a customized quote tailored to your needs. Please fill out the form below, and we'll get back to you as soon as possible.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Recombinant Toxocara Canis 26 kDa Secreted Antigen (TES-26), C-His

Cat. No.VG2C51

Product TypeVeterinary Antigens

Size

Product Overview

BioVenic's Recombinant Toxocara Canis 26 kDa Secreted Antigen (TES-26), C-His is a recombinant protein expressed from Yeast. Its predicted molecular weight is 27.9 kDa. The purity is>85% (SDS-PAGE).

Specifications

Type Recombinant Protein
Species Parasite
Expression System Yeast
Purity >85% (SDS-PAGE)
Predicted Molecular Weight 27.9 kDa
Physical State Lyophilized
Formulation Tris/PBS-based buffer, 5%-50% glycerol

Target Information

The Toxocara Canis 26 kDa Secreted Antigen (TES-26) is a significant component in the excretory-secretory products of T. canis larvae. It is highly immunogenic and has been widely used in veterinary medicine for the diagnosis of toxocariasis. TES-26 is involved in lipid binding and immune evasion, helping the parasite survive within the host. In diagnostic assays, TES-26 has shown high sensitivity and specificity, making it a valuable tool for serological detection of Toxocara infections. It is also being explored for its potential in developing vaccines and immunodiagnostic methods.

Protein Toxocara Canis 26 kDa Secreted Antigen (TES-26)
Protein Synonym Toxocara excretory-secretory antigen 26 (TES-26)
UniProt ID P54190

Shipping and Storage

This product is shipped with ice packs. Lyophilized protein can be stored at -20°C for 1 year. After reconstitution, the protein solution can be stored at 2-8°C for 2-7 days.

Documents

COA

To request a Certificate of Analysis, please enter the Lot No. in the search box. Note: Certificate of Analysis not available for kits.

The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.

User Note

  1. Always centrifuge tubes before opening. Avoid mixing by vortexing or pipetting. Aliquot the reconstituted solution to minimize freeze-thaw cycles.
Inquiry Basket